"Kanta-Hämeen keskussairaala tarjoaa laadukkaita ja monipuolisia erikoissairaanhoidon palveluita Hämeenlinnan ja Riihimäen yksiköissä. Sinua kuunnellen."

During the past decade, Kanta-Häme Central Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kanta-Häme Central Hospital" #1 collaborator was "Linnan Klinikka Oy" with 3 trials as a collaborator, "Finnish Red Cross Blood Service" with 2 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Helsinki University Central Hospital" with 1 trials as a collaborator and "Jyväskylä Central Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Kanta-Häme Central Hospital" are "Metabolic Syndrome" (3 trials), "Atrial Fibrillation" (1 trials), "Colon, Sigmoid" (1 trials), "Coronary Heart Disease" (1 trials) and "Diverticulum" (1 trials). Many other conditions were trialed in "Kanta-Häme Central Hospital" in a lesser frequency.

Most popular intervention types in "Kanta-Häme Central Hospital" are "Dietary Supplement" (2 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cold-pressed turnip rapeseed oil (CTPRO)" (1 trials), "Conservative treatment" (1 trials), "Cyclophosphamide" (1 trials), "ECG monitoring for 3 weeks" (1 trials) and "Elective laparoscopic sigmoid resection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kanta-Häme Central Hospital" are 4 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kanta-Häme Central Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kanta-Häme Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kanta-Häme Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".